# Pilot Study of Posaconazole in Crohn's Disease

> **NCT04966585** · PHASE4 · TERMINATED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Crohn Disease
- CARD9 S12N Risk Allele

## Interventions

- **DRUG:** Posaconazole Delayed Release Oral Tablet
- **DRUG:** Matching Placebo Tablet

## Key facts

- **NCT ID:** NCT04966585
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-17
- **Primary completion:** 2025-01-22
- **Final completion:** 2025-01-22
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Recruitment challenges; changes in manufacturing
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04966585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04966585, "Pilot Study of Posaconazole in Crohn's Disease". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04966585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*